Lainie Jones Comprehensive Cancer Survivorship Act of 2026
- Sponsor
- Sen. Klobuchar, Amy [D-MN]
- Committees
- Finance Committee (primary)
- Last action
- Jul 21, 2026
Bottom line
This bill aims to create a comprehensive federal framework to support cancer survivors from diagnosis through post-treatment, addressing medical, financial, and psychosocial needs.
What it actually does
This bill establishes several programs and amends the Social Security Act to improve cancer survivorship care. It mandates Medicare coverage for cancer care planning, develops an alternative payment model for survivorship care, creates an employment assistance program for survivors, and establishes a comprehensive cancer survivorship program with grants. It also mandates Medicaid and CHIP coverage for healthcare transitions for childhood/adolescent cancer survivors and cancer fertility services, and establishes an Office of Cancer Survivorship within the National Cancer Institute.
Proponents argue
Proponents argue that the bill addresses the growing and often unmet needs of cancer survivors, who face significant long-term physical, emotional, and financial challenges. They emphasize the importance of coordinated care, early intervention, and support for vulnerable populations, highlighting the potential for improved quality of life and better health outcomes for millions of Americans.
Opponents contend
Critics might raise concerns about the potential costs associated with expanding Medicare, Medicaid, and CHIP coverage, as well as establishing new grant programs and offices, particularly without a clear funding offset. They may also question the federal government's role in mandating specific healthcare services that could traditionally be left to state or private insurance decisions, or argue that existing programs could be better utilized.
The bill is moderately complex but its structure and clear definitions make it accessible for a thorough review within a reasonable timeframe.
Sec. 4
Medicare Coverage for Cancer Care Planning and Coordination Services
This section amends the Social Security Act to include "cancer care planning and coordination services" as a covered Medicare benefit. These services involve a physician, physician assistant, or nurse practitioner developing a written or electronic treatment plan for individuals diagnosed with cancer, based on Institute of Medicine guidelines. Services can be furnished at diagnosis, upon condition change, at the end of active treatment, or upon recurrence.
Supporters argue
Supporters argue this ensures cancer patients receive essential, coordinated care planning from diagnosis, which is critical for managing complex treatments and transitions, ultimately improving outcomes and reducing fragmented care.
Critics contend
Some might argue that mandating new services could increase Medicare costs without clear evidence of long-term savings, or that such planning is already part of comprehensive oncology care.
Tradeoffs
Balancing the need for comprehensive care planning for cancer survivors with potential increases in Medicare expenditures and administrative burden for providers.
Sec. 5
Stakeholder Meeting on Survivorship Transition Tools and Information Resources
This section directs the Secretary of Health and Human Services to convene a stakeholder meeting to evaluate strategies for improving transitions from active cancer treatment to long-term survivorship care, including the use of information technology. Following the meeting, the Secretary must publish information resources for patients and providers on consolidating treatment history and survivorship guidelines into personalized care plans, including recommendations for software applications.
Sec. 6
Alternative Payment Model for Quality Cancer Survivorship Care
This section mandates the Secretary of Health and Human Services to develop an alternative payment model for cancer survivorship care under Medicare and Medicaid within one year. The model's design must consider various aspects, including triggers for entry, participation length, episode of care definitions, navigation services, bundled payments, follow-up screenings, shared decision-making, eligible providers, risk stratification, care coordination, social determinants of health, and promotion of prevention and research.
Sec. 7
Cancer Survivor Employment Assistance Program
This section establishes a grant program, administered by the Secretary of Labor in consultation with HHS, to provide education and targeted assistance to eligible cancer survivors facing employment barriers and their families/caregivers. Services include transportation, childcare, nutritional, physical activity, psychosocial, and financial assistance during medical leave, as well as assistance with health insurance premiums and career/training services for those re-entering or unable to return to the workforce. It also helps survivors apply for federal and state benefits.
Sec. 8
Comprehensive Cancer Survivorship Program
This section directs the Secretary of Health and Human Services to establish a comprehensive cancer survivorship program, including a grant program to eligible entities (State comprehensive cancer programs, NCI-designated centers, community-based organizations). Grants are for services that enhance quality of life and improve long-term survival, such as promoting physical activity, mitigating anxiety/depression, utilizing community support, nutrition education, and adherence to screenings. Grantees must provide patient navigator services, culturally competent care, and support caregivers.
Sec. 9
GAO Study on Cancer Survivorship Progress
This section mandates the Secretary to enter an agreement with the Government Accountability Office (GAO) for a study on cancer survivorship progress since the National Cancer Act of 1971. The study will cover care quality, transitions, quality of life, outcomes, disparities, healthcare systems, community services, and payment for survivorship care. It also assesses the role and impact of the Office of Cancer Survivorship. The GAO must hold public meetings with stakeholders and release a report.
Sec. 10
Medicaid Coverage for Childhood and Adolescent Cancer Transition Services
This section amends the Social Security Act to make healthcare transitions for survivors of childhood and adolescent cancer a mandatory Medicaid benefit. These services include transition services from active oncological care to primary care, ensuring development and delivery of survivorship care plans based on Children's Oncology Group (COG) guidelines, exposure-based risk assessment, and at least two survivorship transition care visits per year.
Sec. 11
Medicaid and CHIP Coverage for Cancer Fertility Services
This section mandates Medicaid and CHIP coverage for cancer fertility services for individuals diagnosed with cancer who are undergoing, have undergone, or are preparing for treatment that may cause iatrogenic infertility. Services include fertility treatment, preservation, and long-term storage of genetic material (15 years for under 18, 10 years for 18+). It also prohibits cost-sharing for these services. An exception is made for U.S. territories, where Medicaid coverage is optional.
Sec. 12
Establishment of Office of Cancer Survivorship
This section establishes an Office of Cancer Survivorship within the Office of the Director of the National Cancer Institute (NCI). The Office's purpose is to improve cancer survivorship and its responsibilities include managing a portfolio of research grants on survivorship topics (late/long-term effects, interventions, health delivery models, communication), and professional and survivor education efforts.
Specifies that the initial payment rate for cancer care planning and coordination services under Medicare shall be the same as for transitional care management services (CPT code 99496).
Sec. 4(b)(2)
Why it matters:This is standard legislative practice for setting reimbursement rates by referencing existing codes, rather than creating new, potentially complex, rate-setting mechanisms within the bill itself.
Case for: Supporters would argue that linking the payment rate to an existing, familiar CPT code provides clarity and predictability for healthcare providers, encouraging adoption of the new service without extensive new administrative guidelines.
Case against: Critics might argue that a direct reference to an existing CPT code might not fully capture the unique resource intensity or value of cancer care planning, potentially under- or over-reimbursing the service without a specific, tailored rate-setting process.
Estimated impact: This provision directly influences the financial viability and widespread adoption of the new Medicare benefit for providers.
Prohibits cost-sharing for cancer fertility services under Medicaid and CHIP.
Sec. 11(a)(3) and Sec. 11(b)(2)
Why it matters:This is a standard legislative method for modifying cost-sharing rules within existing federal healthcare programs, rather than creating new, separate language for each benefit.
Case for: Proponents would argue that prohibiting cost-sharing is essential to ensure equitable access to expensive fertility services for low-income cancer survivors, removing financial barriers that could otherwise prevent them from preserving their reproductive options.
Case against: Critics might argue that eliminating cost-sharing for these services could increase the financial burden on state Medicaid and CHIP programs, potentially leading to higher overall program costs without beneficiary contribution.
Estimated impact: Significantly reduces financial barriers for eligible low-income cancer survivors seeking fertility preservation or treatment, potentially increasing utilization of these services.
Sets a staggered effective date for the CHIP amendment on October 1, 2026, while other amendments in Sec. 11 (Medicaid fertility coverage) take effect 18 months after the date of enactment.
Sec. 11(b)(3) and Sec. 11(c)
Why it matters:This could be a tactical maneuver to align with the federal fiscal year for CHIP, or to provide states with more time to implement the more complex Medicaid fertility mandate, potentially easing state-level concerns about immediate implementation burden.
Case for: Proponents would argue that providing different effective dates allows for more practical implementation, giving states adequate time to prepare for the administrative and financial adjustments required for the new mandates.
Case against: Critics might argue that staggered effective dates can create confusion or lead to disparities in access to services between different programs or states during the interim period.
Estimated impact: Affects the timeline for when cancer survivors on CHIP versus Medicaid will gain access to fertility services, and the timeline for states to implement these new requirements.